Search for: "BIOGEN IDEC U.S." Results 1 - 20 of 69
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jul 2021, 8:09 pm by Lawrence B. Ebert
., 571 U.S. 177 (2014).2 To understand the defendants’ arguments, a brief explanation of the legal basis of a misappropriation of idea claim is necessary. [read post]
31 May 2018, 3:02 pm by Lawrence B. Ebert
Spencer [ Pharm Pat Anal. 2014 Mar;3(2):183-98 ] discloses part of the history of Tecfidera and shows that issuesother than patent protection delay entrance of competitors:As a case study of patent coverage for a repurposed drug, Biogen Idec's approach for Tecfidera(®),an oral formulation of dimethyl fumarate, was analyzed. [read post]
11 May 2016, 2:05 pm by Tom Lamb
We start with the apparent increase in the number of Tecfidera - PML cases that have been reported to Biogen Idec and/or the FDA. [read post]
11 Mar 2016, 9:16 am by Lawrence B. Ebert
Biogen IDEC International AG changed its name to Biogen IDEC International GMBH on May 15, 2007. [read post]
13 Aug 2015, 10:56 am
Biogen Idec, Inc. is a case involving a brand-name pharmaceutical product which held that design defect claims against drug manufacturers are preempted as a matter of law. [read post]
12 May 2015, 3:30 pm by James Galvin
Inc. 90271J739 UBS Trigger Phoenix Autocallable Optimization Securities linked to Genworth Financial, Inc. 90271J721 UBS Trigger Phoenix Autocallable Optimization Securities linked to BlackRock, Inc. 90271J689 UBS Trigger Phoenix Autocallable Optimization Securities linked to Baidu, Inc. 90271J671 UBS Trigger Phoenix Autocallable Optimization Securities linked to Bank of America 90271J663 UBS Trigger Phoenix Autocallable Optimization Securities linked to U.S. [read post]
7 Jan 2015, 6:54 am
Biogen Idec Inc., 2014 WL 2882104, at *3 (W.D.N.Y. [read post]
17 Apr 2013, 9:59 pm by Patent Docs
By Donald Zuhn -- Yesterday, in Biogen Idec, Inc. v. [read post]